Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP
Nicola Di Lorenzo, Stavros A Antoniou, Rachel L Batterham, Luca Busetto, Daniela Godoroja, Angelo Iossa, Francesco M Carrano, Ferdinando Agresta, Isaias Alarçon, Carmil Azran, Nicole Bouvy, Carmen Balaguè Ponz
Read Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP by Nicola Di Lorenzo, Stavros A Antoniou, Rachel L Batterham, Luca Busetto, Daniela Godoroja, Angelo Iossa, Francesco M Carrano, Ferdinando Agresta, Isaias Alarçon, Carmil Azran, Nicole Bouvy, Carmen Balaguè Ponz in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7214495.txt.
Introduction
Di Lorenzo and co-authors present the 2020 update of European guidelines on surgery for severe obesity. The document appeared in Surgical Endoscopy. A large panel of surgeons, doctors, diet experts, and other specialists wrote the guidance. A patient representative sat on the panel as well. Three other medical bodies backed the final text.
The panel checked the research behind each weight-loss operation before making its calls. Options range from standard operations to newer devices and gut treatments. For some newer methods, patients lost weight with mostly mild side effects. Serious problems were rare in the trials they reviewed. Still, the proof behind many of these methods was weak. Doctors gain a clear, graded map of the choices for treating severe obesity.
Catalog record
| CREATOR | Nicola Di Lorenzo, Stavros A Antoniou, Rachel L Batterham, Luca Busetto, Daniela Godoroja, Angelo Iossa, Francesco M Carrano, Ferdinando Agresta, Isaias Alarçon, Carmil Azran, Nicole Bouvy, Carmen Balaguè Ponz |
|---|---|
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 104 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP By Nicola Di Lorenzo, Stavros A Antoniou, Rachel L Batterham, Luca Busetto, Daniela Godoroja, Angelo Iossa, Francesco M Carrano, Ferdinando Agresta, Isaias Alarçon, Carmil Azran, Nicole Bouvy, Carmen Balaguè Ponz Published in: Surgical Endoscopy DOI: 10.1007/s00464-020-07555-y ABSTRACT Abstract Background Surgery for obesity and metabolic diseases has been evolved in the light of new scientific evidence, long-term outcomes and accumulated experience. EAES has sponsored an update of previous guidelines on bariatric surgery. Methods A multidisciplinary group of bariatric surgeons, obesity physicians, nutritional experts, psychologists, anesthetists and a patient representative comprised the guideline development panel. Development and reporting conformed to GRADE guidelines and AGREE II standards. Results Systematic review of databases, record selection, data extraction and synthesis, evidence appraisal and evidence-to-decision frameworks were developed for 42 key questions in the domains Indication; Preoperative work-up; Perioperative management; Non-bypass, bypass and one-anastomosis procedures; Revisional surgery; Postoperative care; and Investigational procedures. A total of 36 recommendations and position statements were formed through a modified Delphi procedure. Conclusion This document summarizes the latest evidence on bariatric surgery through state-of-the art guideline development, aiming to facilitate evidence-based clinical decisions. Electronic supplementary material The online version of this article (10.1007/s00464-020-07555-y) contains supplementary material, which is available to authorized users. Keywords: Bariatric surgery, Obesity, Guidelines, EAES, GRADE, AGREE II PREAMBLE It has been 14 years since EAES has launched the 2004 guidelines on obesity surgery. A lot has changed in the field since then. “Historical” techniques developed by the pioneers of bariatric surgery were virtually abandoned (e.g. vertical gastroplasty). Plenty of innovations were added to the armamentarium of healthcare professionals for the operative and perioperative management of bariatric patients. Sleeve gastrectomy, although considered experimental in 2004, has become the most common bariatric procedure. Most recent techniques, such as gastric plication, one-anastomosis bypass and endoluminal procedures are gaining increasing attention. Reiterative (redo) surgery has gained the interest of several bariatric surgeons, although clear indications and even a common definition are lacking. Importantly, laparoscopic surgery is now considered the gold standard approach for bariatric surgery. Under consideration of the above, these guidelines focus exclusively on minimally invasive bariatric surgery and common surgical techniques. Techniques which are now considered obsolete, although properly addressed in the previous guidelines, are not included in this update. Furthermore, the following topics are not addressed herein: modified laparoscopy (natural orifice transluminal, single-incision and robotic surgery), intragastric balloons, the impact of emerging technologies (3-D, fluorescence, hybrid) and pure metabolic surgery (without the obesity parameter). Former standards of clinical guidance development, although of quality at the time, were replaced by the most evidence-based development and reporting standards summarized by the GRADE methodology and AGREE II guidelines. The support of the EAES Guideline Subcommittee is hereto commended. The complex treatment of obesity and its comorbidities requires multidisciplinary integration. To this end, we invited the participation of European organizations involved in the research and management of obesity. The European Chapter of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO-EC), the European Association for the Study of Obesity (EASO) and the European Society for the Peri-operative Care of the Obese Patient (ESPCOP) joined their forces with EAES to produce high quality work. Their representatives carried a wide variety of competencies (psychologists, obesity physicians, nutritional experts, anesthetists, laparoscopic surgeons) and comprised a concerted multidisciplinary panel. This is the first guideline with active involvement of a patient representative from the EASO patient task force. Upon completion of the guideline manuscript, 2 prominent experts in bariatric surgery from outside Europe were invited to appraise the work against AGREE II criteria and provided their assessment with the AGREE II tool. Finally, we are obligated to deeply thank all those who have contributed to this project, which we hope will contribute to the quality of healthcare in bariatric patients in Europe. Nicola Di Lorenzo & Gianfranco Silecchia Content Coordinators Obesity is a multifactorial disease caused by a combination of genetic, environment and metabolic factors [1]. From a public health perspective, obesity is a major risk factor for a range of chronic diseases including type 2 diabetes, cardiovascular diseases and cancer [2]. History The first guidelines endorsing surgery for the management of morbid obesity were published in 1991 by the US National Institutes of Health (NIH) [3]. After this first regulatory act, several international guidelines and consensus projects recommended bariatric surgery as an effective treatment of weight loss and obesity-related comorbidities. After the introduction of laparoscopic bariatric surgery, EAES and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) launched clinical practice guidelines in 2004 and 2008, respectively [4, 5]. The “Interdisciplinary European Guidelines” on surgery for severe obesity were published in 2008, and updated in 2014 through an expert-based consensus process [6, 7]. Rationale and objective The growing burden of obesity in both industrialized and non-industrialized countries [2], the recognition of obesity as a disease in 2013 by the American Medical Association and other regulatory bodies [8], the ever-increasing research evidence in the field and the lack of recent clinical guidance, mandate an urgent need to incorporate latest evidence into clinical practice guidelines. EAES recognized this need and decided to sponsor the present update, which ultimately aims to inform healthcare in bariatric patients. Where do these guidelines apply? These guidelines apply to adult (age > 18) patients with body mass index (BMI) > 35 kg/m2 who are considered fit for surgery and with no contraindications to laparoscopic surgery, unless otherwise indicated. They do not apply to the pediatric population. Healthcare systems, infrastructures, human and financial resources across European countries were considered upon developing these guidelines. Therefore, they are primarily intended to be applicable in European countries, although some recommendations might be applicable to other regions with modifications. Who are the target users? The present guidelines may be used by healthcare professionals, including bariatric surgeons, laparoscopic surgeons, obesity physicians, anesthetists, general practitioners, nutritional experts, psychologists, obstetrics and gynecologists, anesthetic and intensive care unit staff; and may be used as a reference to policymakers, such as European and national authorities, healthcare administrators and health insurance providers, under consideration that the external validity may vary across countries, regions and healthcare institutions. How long are these guidelines valid for? In view of current and ongoing research in the field, these guidelines are valid from publication up to December 2024. Target users are instructed to monitor upcoming research (research published from November 2018 onwards) which might provide evidence further supporting or even negating recommendations provided herein. For further information, see Disclaimer. Update and monitoring The content coordinators will monitor the literature and will recommend an update of these guidelines in 2023, unless developments in the field and emerging evidence will suggest an earlier or later update. A web-based survey of EAES, IFSO-EC, EASO and ESPCOP is planned to be launched in October 2021 to assess guidelines use among healthcare professionals and collect feedback on implementation barriers. MATERIAL AND METHODS Please see Supplementary file 1 for a detailed report of the methodology. This guideline was developed in accordance with the GRADE methodology and complied with AGREE II guideline development and reporting standards [9, 10]. Institutional review board